Do not take Ramipril Cinfa if you may be affected by any of the above conditions. If you are unsure, speak with your doctor before taking Ramipril Cinfa.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ramipril Cinfa:
- an angiotensin II receptor antagonist (ARA) (also known as “sartanes” - for example, valsartán, telmisartán, irbesartán), particularly if you have kidney problems related to diabetes.
- aliskirén.
Your doctor may need to monitor your renal function, blood pressure, and electrolyte levels in your blood (such as potassium) at regular intervals.
See also the information under the heading “Do not take Ramipril Cinfa”.
Children and adolescents
Administration of Ramipril Cinfa is not recommended in children and adolescents under 18 years of age, as the safety and efficacy of ramipril have not yet been established in children.
If any of the above conditions may affect you (or you are unsure), speak with your doctor before taking Ramipril Cinfa.
Other medications and Ramipril Cinfa
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, as Ramipril Cinfa may affect how these medications work. Similarly, some medications may affect how Ramipril Cinfa works.
Inform your doctor if you are taking any of the following medications, which may make Ramipril Cinfa work less effectively:
Inform your doctor if you are taking any of the following medications, as they may increase the risk of adverse effects if combined with Ramipril Cinfa:
Inform your doctor if you are taking any of the following medications. Their effect may be affected by Ramipril Cinfa:
If any of the above conditions may affect you (or you are unsure), speak with your doctor before taking Ramipril Cinfa.
Taking Ramipril Cinfa with food and alcohol
Pregnancy and breastfeeding
Pregnancy
You should speak with your doctor if you think you are (or may be) pregnant.Do not take Ramipril Cinfa during the first 12 weeks of pregnancy, and do not take it after week 13, as its use during pregnancy may cause harm to the baby.
If you become pregnant while taking Ramipril Cinfa, inform your doctor immediately. The change to an alternative suitable treatment should be made before a planned pregnancy.
Lactation
Do not take Ramipril Cinfa if you are breastfeeding.
Consult your doctor or pharmacist before taking any medication.
Driving and operating machines
You may feel dizzy while taking Ramipril Cinfa,which is more likely to occur when starting Ramipril Cinfa or starting a higher dose.Do not drive or operate tools or machines if this occurs.
Ramipril Cinfa tablets contain lactose monohydrate.If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Ramipril Cinfa tablets contain sodium:This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist.In case of doubt, consult with your doctor or pharmacist.
Ramipril Cinfa 2.5 mg tablets:
This concentration is not suitable for doses lower than 1.25 mg.
Amount to take
Hypertension treatment
To reduce the risk of heart attack or stroke
Renal disease treatment to reduce or delay progression
Heart failure treatment
Post-myocardial infarction treatment
Older patients
Your doctor will reduce the initial dose and adjust your treatment more slowly.
Take this medication
If you take more Ramipril Cinfa than you should
Consult your doctor immediately or go to the nearest hospital emergency room.In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Do not drive to the hospital, ask someone to take you or call an ambulance. Bring the medication packaging with you. This way, the doctor will know what medication you have taken.
If you forgot to take Ramipril Cinfa
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Ramipril Cinfa and seek immediate medical attention if you notice any of the following severe side effects, you may need urgent medical treatment:
Inform your doctor immediately if you experience:
Other side effects include:
Inform your doctor if any of the following symptoms worsen or last more than a few days.
Frequent(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 100 people)
Very rare(may affect up to 1 in 10,000 people)
Other side effects reported:
Inform your doctor if any of the following symptoms worsen or last more than a few days.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it's about possible side effects that don't appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above250C. Store in the original packaging to protect it from moisture.
Bottle 1,000 tablets: Shelf life once opened: Use within 12 months of first opening the HDPE bottle.
Keep the HDPE bottle tightly closed to protect the medication from moisture.
Do not use this medication after the expiration date that appears on the packaging, bottle label, or blister pack after CAD.The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or trash.Deposit the packaging and medications you no longer need at the SIGRE collection point at the pharmacy.In case of doubt, ask your pharmacist how to dispose ofthepackaging andmedications that you no longerneed. By doing so, you will help protect the environment.
Composition of Ramipril Cinfa
Appearance of the product and contents of the package
Ramipril Cinfa 2.5 mg tablets:
Uncoated tablets, yellowish to yellow in color, cylindrical, 5 mm in diameter, with flat, beveled edges, engraved with the letter “H” and the number “18”, separated by a groove on one face and smooth on the other face. The tablet can be divided into two equal doses.
-HDPE white opaque bottle with a PP screw cap.
Ramipril Cinfa 2.5 mg tablets:
Blister: 20, 28, 30, 50, 60, 90, 98, 100, and 500 tablets
HDPE bottle: 30 and 1,000 tablets (clinical packaging)
Only some packaging sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Industrial Estate Areta.
31620 Huarte (Navarra)-Spain
Responsible manufacturer:
Galenicum Health S.L.U
Calle San Gabriel, 50
Esplugues de Llobregat
08950 Barcelona
Spain
Or
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate,
Hal Far BBG 3000
(Birzebbugia)-Malta
Or
Generis Farmacêutica, S.A.,
Rua João de Deus, n.o 19,
Venda Nova, 2700-487
Amadora, Portugal.
This medicine is authorized in the member states of the European Economic Area with the following names:
FranceRAMIPRIL ARROW LAB 2.5 mg tablet
ItalyRamipril Aurobindo 2.5 mg tablets
MaltaRamipril Aurobindo 2.5 mg tablets
PolandAWERPIL, 2.5mg
SpainRamipril Cinfa 2.5 mg tablets EFG
Revision date of this leaflet: July 2019
More detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/77383/P_77383.html
QR code to:https://cima.aemps.es/cima/dochtml/p/77383/P_77383.html
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.